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a b s t r a c t
Pseudomembranous tracheitis (PMT) is a rare condition most commonly caused by fungal or bacterial
infection that is characterized by a pseudomembrane that partially or completely covers the tracheo-
bronchial tree. PMT is most commonly found in immunocompromised patient populations, such as post-
chemotherapy, AIDS, post-transplant and hematological malignancies. Due to its rarity, PMT is often not
included in the differential diagnosis. This case describes a 65 year old male with persistent fever and
refractory cough despite high dose empiric antibiotics. Subsequent bronchoscopy with biopsy revealed
pseudomembranous tracheitis due to Aspergillus fumigatus in the setting of T-cell lymphoma. PMT should
be considered in the differential diagnosis of refractory cough in the immunocompromised population.
However, it has been described in patients with nonspeciﬁc respiratory symptoms such as dyspnea,
cough, and other airway issues.
© 2017 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Pseudomembranous tracheitis (PMT) is a rare condition most
commonly caused by fungal or bacterial infection that is charac-
terized by a pseudomembrane that partially or completely covers
the tracheobronchial tree. PMT is most often found in immuno-
compromised patient populations, such as post-chemotherapy,
AIDS, post-transplant, and hematological malignancies [1,2].
Fungal infections of the trachea can cause this rare phenomenon
whichmay potentially lead to necrosis [3]. The pathogens known to
cause this pseudomembranous infection are: Aspergillus, Candida,
Cryptococcus, Rhizopus, and Mucorales [4,5]. In more rare cases,
pseudomembranous tracheitis may be caused by invasive bacterial
pathogens such as Bacillus cereus [6]. PMT should be considered in
the differential diagnosis of refractory cough in the immunocom-
promised population. However, it has been described in patients
with nonspeciﬁc respiratory symptoms such as dyspnea, cough,
and other airway issues [7]. Herein, we present a case of
pseudomembrane tracheitis in the setting of high grade T-cell
lymphoma.
2. Case report
A 65 year old male with a past medical history of non-
obstructive coronary artery disease, urothelial cancer (status post
resection), abdominal aortic aneurysm (status post repair), hypo-
thyroidism, and 50 pack-year history of smoking, was admitted
presenting with recurring fevers and a 30-pound weight loss over
the past several months. A Chest x-ray (CXR) revealed a right mid-
lung consolidation. Computer tomography (CT) showed a left
supraclavicular/lower cervical mass, hilar lymphadenopathy as
well as enlargement of the subcarinal and mediastinal lymph
nodes. Subsequent lymph node biopsy revealed high grade T-cell
lymphoma.
The patient was started up on empiric antibiotic therapy but
continued to be febrile. He subsequently underwent bronchoscopy
which revealed a pseudomembrane extending from the bronchus
intermedius down to the right lower lobe (Fig. 1). Bronchoscopy
was negative for any masses, abscesses, erosions or areas of
bleeding.
Both an endobronchial biopsy as well as culture of the bron-
chioalveolar lavage revealed Aspergillus fumigatus (Fig. 2).
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Patient was initiated on Voriconazole. Repeat bone marrow bi-
opsy was negative for Aspergillus. The patient was discharged on
Voriconazole and oxygen. Despite treatment the patient died of
progressive pulmonary inﬁltrates and respiratory failure.
3. Discussion
Pseudomembranous tracheitis (PMT) is commonly caused by
fungal or bacterial infection that is characterized by
pseudomembrane formation in the large airways [1,2]. Here we
described a case of a 65-year-old male with undiagnosed malig-
nancy that had developed Aspergillus-related PMT. PMT is a rare
condition that manifests with different symptoms and etiologic
microorganisms. Previously reported cases of PMT have been out-
lined in Table 1.
Invasive pulmonary aspergillosis (IPA) is themost common form
of disease caused by Aspergillus species infection. In addition, a rare
form of IPA is an infection of the tracheobronchial tree, called
Aspergillus Tracheobronchitis (AT) [17]. Four types of AT: ulcerative
tracheobronchitis, obstructive bronchial aspergillosis, aspergillus
bronchitis, and pseudomembranous necrotizing bronchial asper-
gillosis, or PMT have been described [1,2]. The pseudomembrane is
thought to be derived from ﬁbrin, hyphae, and necrotic tissue [12].
Other fungi such as Rhizopus, Cryptococcus and Candida can also
form a pseudomembrane via similar mechanisms [4,5]. Rarely vi-
ruses may be implicated in PMT. Known causes of PMT have been
outlined in Table 2.
Patients with pseudomembranous tracheitis typically present
symptoms of dyspnea, fever, non-resolving cough, and chest pain.
Dyspnea, as one of the presenting symptoms, is usually caused by
the pseudomembrane obstructing the airways to the lungs [11].
Colonies of fungi create plaques that line the bronchi which leads to
a necrotizing bronchitis. Most common signs and symptoms of PMT
are outlined in Table 3.
PMT is a rare condition, therefore a strong clinical suspicion is
Fig. 1. Bronchoscopy shows mucous-like layer in the bronchotrachial tree. A) Right upper lobe apico-posterior B) Bronchus intermedius C) Secondary carina right side.
Fig. 2. Microscopic view of biopsy shows strains of Aspergillus fumigatus with char-
acteristic hyphae.
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needed to diagnose this condition. Bronchoscopy is essential to
discover pseudomembrane in the airways. A pseudomembrane has
the potential to form and constrict the airways, thus causing the
symptoms that are associated with PMT [7]. Based on pathological
tissue, brush smear, and ﬂuid from bronchial that are obtained by a
bronchoscopy, the results can lead to a diagnosis of airway asper-
gillus infection and the type of Aspergillus as well [11]. In our case
non resolution of inﬁltrates despite adequate antibiotic therapy
prompted us to perform a bronchoscopy.
Since pseudomembranous tracheitis is mostly caused by fungal
infection, a range of antifungal treatments would deem most
effective towards the condition. Table 1 suggests that amongst
health care providers intravenous Amphotericin B is the initial
treatment of choice [11]. Other treatments such as voriconazole,
itraconazole, and echinocandins (caspofungin) [5,12] However
recently, Voriconazole has been administered to patients with PMT
due to its better prognosis, as shown in Table 1.
PMT has a high morbidity and mortality in immunosuppressed
patients. This in itself lends to a highmorbidity andmortality that is
associated with opportunistic infections. It has been reported that
Table 1
Cases of PMT.
Author Primary disease Causes Organism Signs/Symptoms Treatment Outcomes
Williams et al.
[5]
Leukemia Stem cell
transplantation
secondary to
pancytopenia
Aspergillus Progressive cough,
nausea
Amphotericin B (IV), Amphotericin B (inhaled),
caspofungin (IV)
Deceased
Strauss et al.
[6]
Unknown Aplastic Anemia Bacillus
cereus
Petechiae, weakness,
dyspnea
Broad-spectrum antibiotic, anti-viral, antifungal
therapy
Deceased
(multiple organ
failure)
Chang et al.
[8]
Pt. 1: Diabetes mellitus
Pt. 2: Diabetes
Diabetic ketoacidosis
Diabetic ketoacidosis
Aspergillus
Aspergillus
Chest pain, cough,
dyspnea, wheeze
Non-productive
cough, right side chest
pain, fever
Parental amphotericin B
amphotericin B
Deceased (septic
shock)
Improved
Tait et al. [7] Pt. 1:Non-Hodgkin's
lymphoma
Pt. 2: Systemic lupus
erythematosus-like
disorder
Neurtopenia
Neurtopenia
Aspergillus
Aspergillus
Weight loss, anorexia,
non-productive cough,
and pyrexia
Weight loss,
polyarthralgia, night
sweats, pyrexia
amphotericin B
intravenous amphotericin B (1 mg/kg/day),
ﬂucytosine (120 mg/kg/day), and oral
itraconazole (600 mg/day) commenced,
Deceased
Deceased
(respiratory
failure)
Hines et al. [9] Pt.1: COPD
Pt.2: Hodgkin's
lymphoma
Pt. 3 Myelodysplastic
syndrome
Pt. 4 Hepatic lesions
Respiratory arrest
Neutropenia
Bone marrow
transplant
Neutropenia
Aspergillus
Aspergillus
Aspergillus
Aspergillus
Fever, wheezing
Fever
Fever, hypotension
Epigastric and lower
back pain
Vancomycin, Clindamycin, Amikacin
Amphotericin B
Amphotericin B
Broad spectrum antibiotics
Deceased
Deceased
(respiratory
failure)
Deceased
(progressive
respiratory
insufﬁciency)
Deceased
Pornsuriyasak
et al. [10]
Tuberculous Tuberculous tracheal
stenosis
Aspergillus Fever, Dyspnea, Chest
pain
Oral voriconazole Nebulized amphotericin B Cured
Huang et al.
[11]
16 cases:
56.3% (9/16)
Pulmonary
malignancies
31.3% (5/16)
Bronchial involvement
secondary to non-
pulmonary tumor
12.5% (2/16)
Lung transplant
62.5% (10/16)
Radiotherapy
43.8% (7/16) Repeated
chemotherapy
25.0% (4/16)
Recurrent intervention
therapy by
bronchoscope
Aspergillus 87.5% (14/16)
Progressive dyspnea
75.0% (12/16)
Irritable cough
100% Amphotericin B (inhalation and infusion) 68.8% (11/16)
Deceased
Putnam et al.
[3]
Leukemia Bone marrow
transplantation
secondary to aplastic
anemia
Aspergillus Weakness, fatigue,
dyspnea
Amphotericin B (IV) Deceased
Patel et al.
[12]
Leukemia Pancytopenia Aspergillus Shortness of breath,
cough, pleuritic chest
pain
Amphotericin B (IV) Deceased
(progressive
leukemia and
sepsis)
Williams et al.
[5]
Type 2 Diabetes and
leukemia
allogeneic stem cell
trans- plantation.
Rhizopus
sp.
Progressive cough,
dyspnea, nausea and
emesis
intravenous liposomal amphotericin B, inhaled
amphotericin B, intravenous caspofungin
Deceased
(respiratory
failure)
Le et al. [13] Acute lymphoblastic
leukemia.
chemotherapy Aspergillus. Cough, fever, and
hoarseness.
Intravenous voriconazole
G-CSF
Improved
Argüder et al.
[14]
Diabetes mellitus Inconsistent use of
insulin
Aspergillus Cough, chest pain,
hoarseness, fever,
dyspnea
liposomal amphotericin B Deceased
Ramos et al.
[15]
Cardiac amyloidosis Heart transplant Aspergillus Fever, dyspnea,
wheezing, and a cough
IV voriconazole
IV caspofungin
Improved
Shah et al.
[16]
Stillbirth Pulmonary edema Aspergillus Dyspnea, stridor Voriconazole Improved, then
lost to follow up
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death usually ensues between 1 and 6 weeks after diagnosis [18].
Majority of cases of PMT have resulted in demise as demonstrated
in Table 1. Some causes for death include respiratory failure, septic
shock, or other organ failure. Respiratory failure in PMT may result
from the pseudomembrane constricting the airways and can even
dislodge thus creating a ball valve that leads to obstruction [6,12].
4. Conclusion
PMT is a rare condition that is mostly caused by fungal, and
sometimes, bacterial infection. It usually requires a high index of
suspicion for diagnosis. The prognosis depends on timely diagnosis
and initiation of antifungal therapy.
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Table 2
Causes of Psuedomembranous tracheitis.
Infectious Causes Noninfectious Causes
Fungal
 Aspergillus species
 Candida
 Cryptococcus
 Rhizopus
 Mucorales
Bacterial
 Pseudomonas aeruginosa
 Haemophilus inﬂuenza
 Corynebacterium diphtheriae
 Staphylococcal infections
 a-hemolytic Streptococcus species
 Moraxella catarrhalis
 Bacillus cereus
 Chlamydia species
 Mycoplasma bovis
 Pseudomembranous croup
Viral
 Bovine herpes virus1
 Adenovirus
 Inﬂuenza (co-infection)
Smoke inhalation
Endotracheal intubation
Crohn disease
Stevens-Johnson syndrome
Agents of bioterrorism
Ligneous conjunctivitis
Paraquat ingestion
Adapted from Patel et al. [12].
Table 3
Common symptoms of PMT.
Fever
Dyspnea
Cough
Chest pain
Fatigue
Unilateral wheeze
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